1. Home
  2. UBER vs PRME Comparison

UBER vs PRME Comparison

Compare UBER & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uber Technologies Inc.

UBER

Uber Technologies Inc.

SELL

Current Price

$68.83

Market Cap

140.1B

ML Signal

SELL

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

SELL

Current Price

$3.83

Market Cap

526.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
UBER
PRME
Founded
2009
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.1B
526.0M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
UBER
PRME
Price
$68.83
$3.83
Analyst Decision
Buy
Buy
Analyst Count
49
13
Target Price
★ $98.23
$7.39
AVG Volume (30 Days)
★ 15.2M
5.5M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
3.73
★ 18.18
EPS
★ 1.54
N/A
Revenue
★ $52,017,000,000.00
$4,632,000.00
Revenue This Year
$11.08
$150.97
Revenue Next Year
$15.89
$18.06
P/E Ratio
$45.45
★ N/A
Revenue Growth
18.28
★ 55.28
52 Week Low
$64.04
$2.67
52 Week High
$92.78
$5.91

Technical Indicators

Market Signals
Indicator
UBER
PRME
Relative Strength Index (RSI) 49.41 46.50
Support Level $66.14 $2.94
Resistance Level $78.21 $4.80
Average True Range (ATR) 2.18 0.48
MACD 0.31 -0.10
Stochastic Oscillator 57.33 3.90

Price Performance

Historical Comparison
UBER
PRME

About UBER Uber Technologies Inc.

Uber is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars and autonomous vehicles, but could eventually support additional products and services, such as drone delivery or electric vertical takeoff and landing (eVTOL) technology. Uber operates in over 70 countries and has over 200 million users who order rides or food at least once a month.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: